Login / Signup
Could a Nebulized or Dry Powder Inhalation of a Dopamine D1R Agonist Be a Treatment of Idiopathic Pulmonary Fibrosis?
Bradley T Andresen
Published in:
The Journal of pharmacology and experimental therapeutics (2023)
Keyphrases
</>
idiopathic pulmonary fibrosis
interstitial lung disease
rheumatoid arthritis
replacement therapy